Paul McBarron
2012
In 2012, Paul McBarron earned a total compensation of $422.5K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, and Secretary at Cyclacel Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Bonus | $80,282 |
|---|---|
| Salary | $321,128 |
| Other | $21,125 |
| Total | $422,535 |
McBarron received $321.1K in salary, accounting for 76% of the total pay in 2012.
McBarron also received $80.3K in bonus and $21.1K in other compensation.
Rankings
In 2012, Paul McBarron's compensation ranked 9,264th out of 11,487 executives tracked by ExecPay. In other words, McBarron earned more than 19.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,264 out of 11,487 | 19th |
Division Manufacturing | 3,416 out of 4,253 | 20th |
Major group Chemicals And Allied Products | 939 out of 1,203 | 22nd |
Industry group Drugs | 701 out of 925 | 24th |
Industry Pharmaceutical Preparations | 538 out of 700 | 23rd |
Source: SEC filing on April 2, 2014.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2012.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020